Tonix Pharmaceuticals Holding Corp. filed a Form 8-K on September 22, 2026, disclosing that it entered into a new agreement with a pharmacy benefit manager providing coverage of TONMYA to approximately 21 million Medicare Part D plan beneficiaries, effective immediately.
Key Highlights
- New PBM agreement: Tonix entered into an agreement with a pharmacy benefit manager, effective September 22, 2026, covering TONMYA for approximately 21 million Medicare Part D plan beneficiaries.
- Total coverage reach: Government and commercial coverage of TONMYA is now available to a total of approximately 166 million individuals, according to the filing.
- Effective immediately: The agreement was described as effective immediately as of the date of the announcement.
- Signed by CFO: The filing was signed by Bradley Saenger, Chief Financial Officer of Tonix Pharmaceuticals Holding Corp.
Tonix Pharmaceuticals Adds Medicare Part D Coverage for TONMYA Through New PBM Deal
Tonix Pharmaceuticals Holding Corp. (NASDAQ:TNXP) disclosed in a Form 8-K filed September 22, 2026, that the company entered into an agreement with a pharmacy benefit manager, effective immediately, to provide coverage for TONMYA to approximately 21 million Medicare Part D plan beneficiaries. The company did not identify the specific pharmacy benefit manager by name in the filing.
According to the filing, the addition of this agreement brings the total number of individuals with government and commercial coverage for TONMYA to approximately 166 million. The disclosure was made under Item 8.01 (Other Events) of the Form 8-K and was accompanied by a press release dated September 22, 2026, filed as Exhibit 99.01.
The filing contains forward-looking statements, which the company noted are "based on current expectations, estimates, forecasts and projections about the industry and markets in which we operate and management's current beliefs and assumptions," and are subject to risks and uncertainties detailed in the company's regulatory filings. The company stated it undertakes no obligation to publicly update any forward-looking statement.
What Was Disclosed
Tonix Pharmaceuticals reported a new pharmacy benefit manager agreement extending TONMYA coverage to approximately 21 million Medicare Part D beneficiaries, bringing total government and commercial coverage to approximately 166 million individuals as of September 22, 2026.



Please wait processing your request...